Hemolytic anemia and why patient history matters with Carla Dinardo

In the investigation of immune hemolytic anemia, the ideal scenario involves laboratory results that precisely identify the causative agent, facilitating effective patient treatment. However, there are instances when laboratory findings fail to align with expected outcomes, underscoring the vital role of patient history in guiding further investigations.

Join in this captivating webinar as we delve into intriguing case studies that highlight inconsistencies between test results and the patient’s clinical condition, necessitating deeper exploration and analysis.

Carla Dinardo, the esteemed Director at Fundação Pró‑Sangue São Paulo Hemocenter, will lead the discussion. With a medical degree and specialized training in internal medicine and hematology/hemotherapy, Dinardo brings a wealth of knowledge and experience to her role. As Head of the Immunohematology Division, she has been involved in numerous projects focused on blood group system genetics, red blood cell alloimmunization, and transfusion practices. Notably, Dinardo served as the investigator in the NHLBI REDS III study in Brazil, collaborating with the Vitalant Research Institute in San Francisco. Furthermore, she currently serves as the Director of External Relations at Fundação Pró‑Sangue and represents Latin America as a member of the Young Professional Council of ISBT.

Don’t miss this opportunity to gain insights from Carla Dinardo and explore the intricacies of immune hemolytic anemia investigations. Sign up now to access this enlightening on-demand webinar and stay updated in this evolving field.